【2017年】
著書
[Ⅰ] 著 書
1. Yamamoto Y. Small Artery Occlusive Diseases. In: Caplan L.R., Biller J., Leary M.C., Lo E.H., Thomas A.J., Yenari M., Zhang J.H., editors. Primer on Cerebrovascular Diseases. Cambridge. Academic Press. pp. 377–383, 2017.
2. 徳田隆彦. 特発性正常圧水頭症. 医学書院編. 今日の治療指針 2017年版—私はこう治療している. 東京：医学書院 pp. 931-932, 2017.
3. 徳田隆彦. 6.前頭側頭葉変性症の薬物療法 ②神経内科的側面から. 祖父江元・池田学・中島健二監修. 前頭側頭葉変性症の療養の手引き. 松江市. pp. 47-49, 2017.
4. 徳田隆彦. 第5章 診断・治療の対象としてのバイオマーカー. ４) アルツハイマー病の髄液バイオマーカー研究: 過去・現在・未来. 森啓 編, 実験医学2017年7月増刊号「認知症研究の新時代」. 東京：羊土社. pp. 156-160, 2017.
5. 徳田隆彦, 笠井高士. 神経難病へのエキスパート・アプローチ「第IV章-1. バイオマーカーの開発」. 水澤英洋編. 神経変性疾患ハンドブック (in press).
6. Tokuda T, Ishii R, Tatebe H, Kasai T, El-Agnaf OMA. Alpha-Synuclein in Cerebrospinal Fluid. Kenji Kosaka (Eds). Dementia with Lewy Bodies. Tokyo: Springer Japan, 2016 (in press).
7. 巨島文子. 脳梗塞.高齢者の肺炎.大阪：医薬ジャーナル社. pp. 95-102, 2017.
8. 巨島文子. 摂食嚥下障害に対する栄養療法.日本静脈経腸栄養学会 静脈栄養テキストブック.東京：南江堂. pp.503-511, 2017．
9. 巨島文子. 新版 リハビリテーション医学Q&A-専門医を目指して.東京：医歯薬出版. 2017．
10. 中瀬泰然．急性期の抗血小板療法．必携 脳卒中ハンドブック第3版．東京：診断と治療社．pp. 248-250, 2017.
11. 中瀬泰然．急性期の抗凝固療法．必携 脳卒中ハンドブック第3版．東京：診断と治療社．pp. 251-253, 2017.
12. 松尾雄一郎. Ⅲ章 臨床：疾患別 5. 神経・筋疾患 新版リハビリテーション医学Q&A－専門医を目指して. 水落和也 編. 東京：医歯薬出版. pp. 126-128, 130-131, 2017.
13. 尾原知行. Branch Atheromatous Disease. 生涯教育シリーズ92 脳血管障害診療のエッセンス 日本医師会雑誌第146巻特別号(1) 東京．日本医師会：S160-162, 2017.
14. 濱中正嗣，今井啓輔．全身動脈硬化性疾患の一分症としての頚動脈狭窄症 生活習慣病と頚動脈狭窄症／心血管病，末梢血管病と頚動脈狭窄症／慢性腎臓病と頚動脈狭窄症／頚動脈狭窄症の診療におけるチーム医療の必要性．パーフェクトマスター 頚動脈狭窄症．東京．メジカルビュー社．pp.12-20，2017．
15. 大道卓摩, 徳田隆彦. 第9章. 進行性核上性麻痺. 小野賢二郎監訳. 「アルツハイマー病 認知症疾患 臨床医のための実践ガイド」(Memory Loss, Alzheimer’s Disease, and Dementia, 2nd ed. A.E. Budson & P.R. Solomon著). 東京：朝倉書店. pp. 99-105, 2017.
16. 大道卓摩, 徳田隆彦. II. パーキンソン病の診断, 鑑別. ２．診断に役立つバイオマーカーはありますか？鈴木則宏監修, 服部信孝・下泰司・波田野琢編. 神経内科Clinical Questions & Pearls 「パーキンソン病」. 東京：中外医学社. (in press)
17. 蒔田直輝, 古賀政利, 豊田一則. 頭頸部動脈解離診断 Diagnosis of extra- and intra- cranial cerebral artery dissection V. 動脈・静脈疾患 (四肢体幹) ３ 頸動脈・椎骨動脈解離. 日本臨牀増刊号 動脈・静脈の疾患(上)―最新の診断・治療動向―日本臨牀社 pp.376-382, 2017.
18. 山﨑英一，今井啓輔. 血栓除去機器を使用せずに再開通できた急性脳底動脈閉塞症の一例. 分子脳血管病vol.16.no.2. 先端医学社. pp.77-82, 2017.
[Ⅱ] 総 説
1. 武澤信夫．シンポジウムⅢ：高次脳機能障害：社会的行動障害支援と展望 社会的行動障害と地域支援の現状．高次脳機能研究，37巻3，293-300，2017．
2. 徳田隆彦. Controversies: メタボロームはパーキンソン病のバイオマーカーとして有用か？: 「NO」の立場から. Frontiers in Parkinson Disease 10巻1, 24-27, 2017.
3. 徳田隆彦. アルツハイマー型認知症のバイオマーカーの現状と課題. 老年期認知症研究会誌 21巻4, 39-45, 2017.
4. チェンバーズ・ジェームズ, 徳田隆彦. 特集: 認知症100万人時代を目前に控えて: 最新の診断,マネジメント,そして分子標的治療へ. イヌ, ネコの認知症はヒトのモデルとなるか？ 内科120巻2, 299-301, 2017.
5. 水田依久子, 水野敏樹. 遺伝性脳小血管病のトピックス. 医学のあゆみ, 262巻3: 199-204, 2017.
6. 巨島文子. 摂食嚥下障害の診かた. 神経内科がわかる,好きになる 今日から実践できる診察・診断・治療のエッセンス 神経疾患を病歴聴取と身体所見で鑑別する!レジデントノート18巻17，3094-3099, 2017．
7. 巨島文子. 神経筋疾患に伴う摂食嚥下障害の概説【できる限り口から食べることへの挑戦】 東京：難病と在宅ケア 23巻6，28-31, 2017．
8. 巨島文子. 脳梗塞に伴う摂食・嚥下障害．神経内科87巻6，586-592, 2017．
9. 近藤正樹. 急性期の高次脳機能障害まるわかり，失行．Brain Nursing 33巻8, 19-25, 2017.
10. 近藤正樹. 古典症例の今日的意味．Liepmannから始まる失行．神経心理学 32巻3, 253-259, 2017.
11. 吉田誠克. アレキサンダー病の臨床と病態．Dementia Japan 31巻, 10-17, 2017.
12. 永金義成. 脳梗塞の抗血小板療法. 日本血栓止血学会誌 28: 326-334, 2017.
13. 笠井高士, 徳田隆彦. 特集: 神経疾患の早期診断. パーキンソン病の早期診断. 神経内科86巻1, 23-29, 2017.
14. 笠井高士, 徳田隆彦. 特集III: Parkinson病の画像検査・バイオマーカー: 標準化への道. Parkinson病の生化学的バイオマーカーの標準化. 神経内科86巻4, 499-507, 2017.
15. 笠井高士, 徳田隆彦. 特集: パーキンソン病の認知機能障害—PDの非運動症状としての認知機能障害を見逃さないために 4. PDの認知機能障害と関連するバイオマーカー. 認知症の最新医療 28号, 2018.
16. 笠井高士, 認知症と糖尿病. 京都府立医科大学雑誌, 126巻10, 697-705, 2017.
17. 渡邉明子, 水田依久子, 水野敏樹. CADASILの臨床像と遺伝子異常. 神経内科, 87巻6: 630-637, 2017.
18. 沼宗一郎, 三浦正智, 吉村紳一. 脳血栓回収療法の現状と課題. Medical Science Digest, 43巻11, 552-555, 2017.
19. 沼宗一郎, 三浦正智, 吉村紳一. 脳血栓回収療法の最前線. 神経内科 87巻5, 499-505, 2017.
20. 傳和眞，木下真幸子．高齢者てんかんの特徴．Clinical Neuroscience，35巻7，804-807, 2017.
英文原著
- [Ⅲ] 原 著
＜英文原著＞
1. Yamamoto Y, Nagakane Y, Tomii Y, Toda S, Akiguchi I. The relationship between progressive motor deficits and lesion location in patients with single infarction in the lenticulostriate artery territory. J Neurol. 264: 1381-1387, 2017 Jun 8.
2. Shiogai T, Yamamoto Y, Arima Y, Koyama M, Maejima R, Kasai T, Mizuno T: Propagation of pulse waves in the cervical arteries with reference to intracranial hemodynamics. Neurosonology 30:64, 2017 (abstract).
3. Coler-Reilly ALG, Sato T, Matsuzaki T, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Inoue E, Yamano Y. Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study. Neurotherapeutics. 2017 May 23.
4. Ando M, Hashiguchi A, Okamoto Y, Yoshimura A, Hiramatsu Y, Yuan J, Higuchi Y, Mitsui J, Ishiura H, Umemura A, Maruyama K, Matsushige T, Morishita S, Nakagawa M, Tsuji S, Takashima H. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. J Peripher Nerv Syst. 2017 Jun 29.
5. Majbour NK, Chiasserini D, Vaikath NN, Eusebi P, Tokuda T, van de Berg W, Parnetti L, Calabresi P, El-Agnaf OM. Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease. Sci Rep. 7:40263. doi:10.1038/srep40263, 2017.
6. Yamada S, Ishikawa M, Miyajima M, Atsuchi M, Kimura T, Kazui H, Mori E; SINPHONI-2 Investigators: Disease duration: the key to accurate CSF tap test in iNPH. Acta Neurol Scand. 135(2):189-196, 2017.
7. Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid. JAMA Neurol.74(2):163-172, 2017.
8. Yamada S, Ishikawa M, Miyajima M, Nakajima M, Atsuchi M, Kimura T, Tokuda T, Kazui H, Mori E. Timed up and go test at tap test and shunt surgery in idiopathic normal pressure hydrocephalus. Neurol Clin Pract 7(2): 98-108, 2017.
9. Yamada S, Kimura T, Jingami N, Atsuchi M, Hirai O, Tokuda T, Miyajima M, Kazui H, Mori E, Ishikawa M, SINPHONI-2 Investigators: Disability risk or unimproved symptoms following shunt surgery in patients with iNPH: Post Hoc Analysis of SINPHONI-2. J Neurosurg. 15:1-8, 2016. doi: 10.3171/2016.5.JNS16377. [Epub ahead of print].
10. Mizuta I, Watanabe-Hosomi A, Koizumi T, Mukai M, Hamano A, Tomii Y, Kondo M, Nakagawa M, Tomimoto H, Hirano T, Uchino M, Onodera O, Mizuno T. New diagnostic criteria for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukocencephalopathy in Japan. J Neurol Sci. 381: 62-67, 2017.
11. Mori T, Fujishima I, Wakabayashi H, Oshima F, Itoda M, Kunieda K, Kayashita J, Nishioka S, Sonoda A, Kuroda Y, Yamada M, Ogawa S. Development, reliability, and validity of a diagnostic algorithm for sarcopenic dysphagia．JCSM 2(2)：1-10, 2017．
12. Kuriyama N, Miyajima M, Nakajima M, Kurosawa M, Fukushima W, Watanabe Y, Ozaki E, Hirota Y, Tamakoshi A, Mori E, Kato T, Tokuda T, Urae A, Arai H. Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: Epidemiological and clinical characteristics. Brain Behav. 7(3): e00635. doi: 10.1002/brb3.635, 2017.
13. Kuriyama N, Ihara M, Mizuno T, Ozaki E, Matsui D, Watanabe I, Koyama T, Kondo M, Tokuda T, Tamura A, Yamada K, Akazawa K, Takeda K, Takada A, Mizuno S, Nakagawa M, Watanabe Y. Association between Mid-Regional Proadrenomedullin Levels and Progression of Deep White Matter Lesions in the Brain Accompanying Cognitive Decline. J Alzheimers Dis. 1253-1262. doi:10.3233/JAD-160901, 2017.
14. Ozaki E, Yamada S, Kuriyama N, Matsui D,Watanabe I, Koyama T, Imanishi Y, Inaba M, Watanabe Y. Association of BAP with urinary albumin excretion in postmenopausal, but not premenopausal, non-CKD Japanese women. Sci Rep. in press
15. Miyamoto K, Fujihara K, Kira J, Kuriyama N, Matsui M, Tamakoshi A, Kusunoki S. A nationwide epidemiological study of neuromyelitis optica in Japan. J Neurol Neurosurg Psychiatry. in press
16. Kuriyama N, Ozaki E, Mizuno T, Ihara M, Mizuno S, Koyama T, Matsui D, Watanabe I, Akazawa K, Takeda K, Takada A, Inaba M, Yamada S, Motoyama K, Takeshita W, Iwai K, Hashiguchi K, Kobayashi D, Kondo M, Tamura A, Yamada K, Nakagawa M, Watanabe Y. Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI. J Alzheimers Dis. 2018;61:145-155.
17. Kuriyama N, Inaba M, Ozaki E, Yoneda Y, Matsui D, Hashiguchi K, Koyama T, Iwai K, Watanabe I, Tanaka R, Omichi C, Mizuno S, Kurokawa M, Horii M, Niwa F, Iwasa K, Yamada S, Watanabe Y. Association between loss of bone mass due to short sleep and leptin-sympathetic nervous system activity. Arch Gerontol Geriatr. 2017;70:201-208.
18. Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Takeshita W, Iwai K, Watanabe Y, Nakatochi M, Shimanoe C, Tanaka K, Oze I, Ito H, Uemura H, Katsuura-Kamano S, Ibusuki R, Shimoshikiryo I, Takashima N, Kadota A, Kawai S, Sasakabe T, Okada R, Hishida A, Naito M, Kuriki K, Endoh K, Furusyo N, Ikezaki H, Suzuki S, Hosono A, Mikami H, Nakamura Y, Kubo M, Wakai K. Genetic Variants of RAMP2 and CLR are Associated with Stroke. J Atheroscler Thromb. 24:1267-1281,2017.
19. Matsui D, Watanabe I, Koyama T, Ozaki E, Kuriyama N, Mizuno S, Watanabe Y. Japanese female Kendo practitioners are associated with high radial bone mineral density. J Sports Sci. 35:1-6,2017
20. Sasakabe T, Wakai K, Kawai S, Hishida A, Naito M, Suzuki S, Nindita Y, Arisawa K, Kita Y, Hara M, Kuriyama N, Hirata A, Mikami H, Oze I, Kubo M, Tanaka H, Hamajima N. Modification of the Associations of Alcohol Intake With Serum Low-Density Lipoprotein Cholesterol and Triglycerides by ALDH2 and ADH1B Polymorphisms in Japanese Men.
21. J Epidemiol. 2017, [Epub ahead of print
22. Takagi S, Naito M, Kawai S, Okada R, Nagata C, Hosono S, Nishida Y, Takashima N, Suzuki S, Shimoshikiryo I, Mikami H, Uemura H, Kuriyama N, Ohnaka K, Kubo M, Hamajima N, Tanaka H, Wakai K. Macronutrient intakes and serum oestrogen, and interaction with polymorphisms in CYP19A1 and HSD17B1 genes: a cross-sectional study in postmenopausal Japanese women. Br J Nutr. 118:463-472,2017
23. Horii M, Fujiwara H, Mikami Y, Ikeda T, Ueshima K, Ikoma K, Shirai T, Nagae M, Oka Y, Sawada K, Kuriyama N, Kubo T. Differences in monthly variation, cause, and place of injury between femoral neck and trochanteric fractures: 6-year survey (2008–2013) in Kyoto prefecture, Japan. Clinical Cases in Mineral and Bone Metabolism, 14:23-27, 2017
24. Kobayashi D, Takahashi O, Osugi Y, Kuriyama N, Yokota K. Malignancy risks after herpes zoster: Hospital-based matched cohort study. Eur J Intern Med. 44:e13-e14, 2017
25. Kobayashi D, Kuriyama N, Osugi Y, Arioka H, Takahashi O. Longitudinal relationships between cardiovascular events, risk factors, and time-dependent sleep duration. Cardiol J. 2017, [Epub ahead of print]
26. Okamoto T，Imai K，Hamanaka M，Yamazaki H，Itsukage M，Tsuto K，Yamamoto A，Ioku T，Nakamura T，Kimura M，Kitani K，Umezawa K．A case of acute embolic occlusion of the brachiocephalic artery recanalized with endovascular thrombectomy．JNET 11：315-321．2017．
27. Nakase T, Ishikawa T. The Introduction Timing of Oral Anticoagulants in the Early Phase of Acute Stroke Patients. J Cardiol Clin Res. 5(1): 1093, 2017.
28. Nakase T, Suzuki A. Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke. Stroke Res Therapy. 1(1): 7, 2017.
29. Nakase T, Ishikawa T, Miyata H. Protective effects of connexins in atheromatous plaques in patients of carotid artery stenosis. Neuropathol. 37: 97-104, 2017.
30. Hayashi Y, Nagasawa M, Asano T, Yoshida T, Kimura A, Inuzuka T. Central hypothermia associated with Alexander disease. Clin Neurol Neurosurg. 157:31-33, 2017.
31. Yoshida T, Yasuda R, Mizuta I, Nakagawa M, Mizuno T. Quantitative evaluation of brain stem atrophy using MRI in adult patients with Alexander disease. Eur Neurol, 77： 296-302, 2017.
32. Kawahara Y, Yamashita T, Ohta Y, Sato K, Nomura E, Takemoto M, Hashikawa N, Shang J, Yoshida T, Abe K. Alexander’s disease type 2 with a novel glial fibrillary acidic protein gene mutation and unique clinical features. Neurol Clin Neurosci. 5： 183-185, 2017.
33. Yoshida T, Yasuda R, Mizuta I, Nakagawa M, Mizuno T. JAPAN Alexander Disease Study Group. Quantitative Evaluation of Brain Stem Atrophy Using Magnetic Resonance Imaging in Adult Patients with Alexander Disease. Eur Neurol. 77(5-6): 296-302, 2017.
34. Kasai T, Sakaue S, Mizuta I, Suematsu M, Osone S, Azuma Y, Imamura T, Tokuda T, Kanno H, El-Agnaf O, Morimoto M, Nakagawa M, Hosoi H, Mizuno T. Early-onset Parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: Do PGK-1 mutations contribute to vulnerability to parkinsonism? NPJ Parkinson Dis. 31(3): 13, 2017. doi:10.1038/s41531-017-0014-4, 2017.
35. Kasai T, Kondo M, Ishii R, Tanaka A, Ataka S, Shimada H, Tomiyama T, Mori H, Taylor M, Allsop D, Nakagawa M, Mizuno T, Tokuda T. Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease. PLoS One. 12(4): e0174630. doi: 10.1371/journal.pone.0174630, 2017.
36. Kasai T, Tatebe H, Kondo M, Ishii R, Ohmichi T, Yeung WTE, Morimoto M, Chiyonobu T, Terada N, Allsop D, Nakagawa M, Mizuno T, Tokuda T. Increased levels of plasma total tau in adult Down syndrome. PLoS One. 12(11):e0188802. doi: 10.1371/journal.pone.0188802, 2017.
37. Uehara T, Minematsu K, Ohara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K. Incidence, predictors, and etiology of subsequent ischemic stroke within one year after transient ischemic attack. Int J Stroke. 12:84-89,2017.
38. Uehara T, Ohara T, Minematsu K, Nagatsuka K, Toyoda K. Predictors of stroke events in patients with TIA attributable to intracranial stenotic lesions. Intern Med. doi: 10.2169/internalmedicine.9447-17,2017.
39. Shimada H, Kitamura S, Shinotoh H, Endo H, Niwa F, Hirano S, Kimura Y, Zhang MR, Kuwabara S, Suhara T, Higuchi M. Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer’s disease spectrum brains: A [(11)C]PBB3-PET study. Alzheimers Dement (Amst) 6: 11-20, 2016.
40. Osako M, Itsumi M, Yamaguchi H, Takeuchi H, Yamaoka S, A20 restores phorbol ester-induced differentiation of THP-1 cells in the absence of nuclear factor-κB activation. J Cell Biochem. 2017 Aug 3. doi: 10.1002/jcb.26308.
41. Okada Y, Ochi H, Fujii C, Hashi Y, Hamatani M, Ashida S, Kawamura K, Kusaka H, Matsumoto S, Nakagawa M, Mizuno T, Takahashi R, Kondo T. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production. J Autoimmun. 2017 Nov 13. pii: S0896-8411(17)30534-6.
42. Garg N, Park SB, Yiannikas C, Vucic S, Howells J, Noto YI, Mathey EK, Pollard JD, Kiernan MC. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment. Muscle Nerve. 2017 Nov 11. doi: 10.1002/mus.26010. [Epub ahead of print] PubMed PMID: 29130507.
43. Noto YI, Simon N, Shibuya K, Matamala JM, Dharmadasa T, Kiernan MC. Dynamic muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug; 18(5-6):404-410. doi: 10.1080/21678421.2017.1286355. Epub 2017 Feb 10. PubMed PMID: 28613097.
44. Shibuya K, Simon NG, Geevasinga N, Menon P, Howells J, Park SB, Huynh W, Noto YI, Vucic S, Kiernan MC. The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis. Clin Neurophysiol. 2017 Jun; 128(6):1075-1082. doi:10.1016/j.clinph.2017.03.004. Epub 2017 Mar 15. PubMed PMID: 28400096.
45. Noto YI, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Kiernan MC. Detection of fasciculations in amyotrophic lateral sclerosis: The optimal ultrasound scan time. Muscle Nerve. 2017 Dec; 56(6):1068-1071. doi:10.1002/mus.25607. Epub 2017 Apr 10. PubMed PMID: 28187527
46. Shahrizaila N, Noto Y, Simon NG, Huynh W, Shibuya K, Matamala JM, Dharmadasa T, Devenney E, Kennerson ML, Nicholson GA, Kiernan MC. Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy. Clin Neurophysiol.2017 Jan; 128(1):227-232. doi: 10.1016/j.clinph.2016.11.010. Epub 2016 Nov 21.PubMed PMID: 27940147.
47. Shibuya K, Park SB, Howells J, Huynh W, Noto YI, Shahrizaila N, Matamala JM, Vucic S, Kiernan MC. Laterality of motor cortical function measured by transcranial magnetic stimulation threshold tracking. Muscle Nerve. 2017 Mar; 55(3):424-427. doi: 10.1002/mus.25372. Epub 2016 Dec 28. PubMed PMID: 27511622.
48. Matsumoto S, Murakami N, Koizumi H, Takahashi M, Izumi Y, Kaji R. Evaluation of the Edrophonium Challenge Test for Cervical Dystonia. Intren Med. 56(18):2415-2421, 2017.
49. Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, Kondo M, Allsop D, Tokuda T. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and Down syndrome. Mol Neurodegener 12:63 doi: 10.1186/s13024-017-0206-8, 2017.
50. Yokoya S, Hino A, Takezawa H, Katsumori T, Goto Y, Hashimoto Y, Oka H. Microsurgical removal of snagged stent retriever during endovascular embolectomy for acute ischemic stroke: A case report. World Neurosurg. pii: S1878-8750(17)32183-6. 2017.
51. Kitani-Morii F, Imamura K, Kondo T, Ohara R, Enami T, Shibukawa R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H. Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature. Neuroreport. 28(13): 814-821, 2017.
52. Tsuji Y，Noto Y，Shiga K，Teramukai S，Nakagawa M，Mizuno T．A muscle ultrasound score in the diagnosis of amyotrophic lateral sclerosis．Clin Neurophysiol．128(6): 1069-1074，2017．
53. Ohmichi T, Kondo M, Itsukage M, Koizumi H, Matsushima S, Kuriyama N, Ishii K, Mori E, Yamada K, Mizuno T, Tokuda T. Usefulness of the Convexity Apparent Hyper-perfusion (CAPPAH) Sign in 123I-iodoamphetamine Brain Perfusion Single Photon Emission Computed Tomography for the Diagnosis of Idiopathic Normal Pressure Hydrocephalus. J Neurosurg 2017 (in press).
54. Funatsu N, Hayakawa M, Tokuda N, Toyoda K．Transient Prosopometamorphopsia Restricted to the Left Eye Caused by Ischemia at the Right Splenium of the Corpus Callosum．Internal Med．56：2933-2935, 2017．
55. Yasuda R, Yoshida T, Mizuta I, Nakagawa M, Mizuno T. A novel three-base duplication, E243dup, of GFAP identified in a patient with Alexander disease. Hum Genome Var. 4: 17028, 2017.
56. Matsuura J, Fujii A, Mizuta I, Norose K, Mizuno T. Cerebral Toxoplasmosis Diagnosed by Nested-Polymerase Chain Reaction in a Patient with Rheumatoid Arthritis. Intern Med. (in press)
57. Takahashi H, Kimura T, Yuki N, Yoshioka A. An Adult Case of Recurrent Guillain-Barré Syndrome with Anti-galactocerebroside Antibodies. Intern med. doi: https://doi.org/10.2169/internalmedicine.8941-17, 2017.
58. Takahashi H, Ueshima T, Goto D, Kimura T, Yuki N, Inoue Y, Yoshioka A. Acute
Tetraparesis with Respiratory Failure after Steroid Administration in a Patient with a Dural Arteriovenous Fistula at the Craniocervical Junction. Intern med. doi: https://doi.org/10.2169/internalmedicine.9115-17, 2017.
59. Takahashi H, Kimura T, Yuki N, Yoshioka A. A Case of Stroke-like Migraine Attacks after Radiation Therapy (SMART) Syndrome Followed by Cerebral Infarction. Intern med.(in press)
60. Makita N, Ohara T, Fujinami J, Akioka S, Mizuno T. Serial changes of carotid wall thickening on ultrasound in Takayasu arteritis. Journal of the Neurological Sciences 380: 234-235, 2017.
61. Kojima Y, Noto Y, Takewaki D, Tokuda N, Shiga K, Hamano A, Mizuta I, Muranishi M, Kasai T, Nakagawa M, Mizuno T．Charasteristic Posterior-dominant Lower Limb Muscle Involvement in Linb-girdle Muscular Dystrophy due to a DNAJB6 Phe93Leu Mutation．Intern Med. 56: 2347-2351, 2017．
62. Shinomoto M, Kawasaki T, Sugahara T, Nakata K, Kotani T, Yoshitake H, Yuasa K, Saeki M, Fujiwara Y. First report of human parechovirus type 3 infection in a pregnant woman. Int J Infect Dis. 59: 22-24, 2017.
63. Nakamura T, Fujikoshi S, Funai J, Matsumura T．Disease-modifying effect of solanezumab evaluated by delayed-start analysis in a Japanese subpopulation with mild Alzheimer’s disease．Neurology and Clinical Neuroscience 5. 141—149, 2017.
64. Takewaki D, Kasai T, Itoh K, Shiga K, Tokui M, Tanaka A, Noto Y, Ohara T, Mizuno T. Case of neuromyelitis optica with recurrent stomach carcinoma. Clinical and Experimental Neuroimmunology. Doi: 10.1111/cen3.12417, 2017.
65. Kishimoto I, Shinohara S, Ueda T, Tani S, Yoshimura H, Imai Y. Orbital apex syndrome secondary to a fungal nasal septal abscess caused by Scedosporium apiospermum in a patient with uncontrolled diabetes: a case report. BMC Infectious Diseases. 17:649 2017.
66. Taki M, Nakamura T, Matsuura H, Hasegawa T, Sakaguchi H, Morita K, Ishii R, Mizuta I, Kasai T, Mizuno T, Hirano S. Cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Auris Nasus Larynx (in press)
＜和文原著＞
1. 中島健二. 再考 高齢社会と認知症⑩ 高齢者介護の質を高めよう. 知恩, 872：24-27, 2017.
2. 中島健二. 再考 高齢社会と認知症⑪ たのしいリハビリテーション. 知恩, 873：24-27, 2017.
3. 中島健二. 再考 高齢社会と認知症⑫ 老衰,この美しい病名. 知恩, 874：24-27, 2017.
4. 中島健二. 再考 高齢社会と認知症⑬われ思う,ゆえに我あり. 知恩, 875：24-27, 2017.
5. 中島健二. 再考 高齢社会と認知症⑭私はロボットより人の手のぬくもりがいい. 知恩, 876：24-27, 2017.
6. 中島健二. 再考 高齢社会と認知症⑮ 高齢ドライバー. 知恩, 877：24-27, 2017.
7. 中島健二. 再考 高齢社会と認知症⑯ 木を見て山を見ず. 知恩, 878：24-27, 2017.
8. 中島健二. 再考 高齢社会と認知症⑰人生の最終コーナーに向けて―「ゆりかごから墓場まで」―. 知恩, 879：24-27, 2017.
9. 中島健二. 再考 高齢社会と認知症⑱二〇二五年問題を皆で考える. 知恩, 880：24-27, 2017.
10. 中島健二. 再考 高齢社会と認知症⑲死に方じょうず. 知恩 881：24-27, 2017.
11. 中島健二. 再考 高齢社会と認知症⑳子孫に残す最高のプレゼント. 知恩, 882：24-27, 2017.
12. 中島健二. 再考 高齢社会と認知症㉑空念仏,実念仏. 知恩, 883：24-27, 2017.
13. 塩貝敏之，山本真佑実，有馬有香，小山真理,前島 亨，笠井高士，水野敏樹．心血管と頭蓋内からの脈波伝搬が頭蓋内血流動態に及ぼす影響：頸部動脈におけるwave intensity (WI) 解析から．Neurosonology 30 Suppl: 103, 2017 (abstract)
14. 武澤信夫，平野哲雄，小泉英貴，木村彩香，近藤正樹，中川正法，水野敏樹．脳卒中地域連携パスにおける高次脳機能障害と介護保険や社会復帰の現状．京都医学会雑誌，64巻（2），67-71，2017．
15. 杉本英造, 平位喜七郎, 郷原憲一, 安野哲也, 有井悦子. 平成28年度 精神衛生研究会事業報告. 京都市学校医会誌, 第27号: 87-88, 2017.
16. 杉本英造, 平位喜七郎, 林 鐘声, 有井悦子, 安野哲也. アンケート調査からみた学校医の役割について 平成１８年度調査と比較し１０年経過しどのように変化したか. 京都市学校医会誌, 第27号: 70-78, 2017.
17. 渡部真志, 松本雄志, 岡本憲省, 奥田文悟, 水田依久子, 水野敏樹. 前頭葉症状で初発したhereditary sensory and autonomic neuropathy 1E（HSAN1E）の1例. 臨床神経，57巻(12): 753－758，2017.
18. 滋賀健介，辻有希子，能登祐一，水野敏樹，中川正法．18年の経過で軸索変性が進行した多巣性運動ニューロパチーの1例(原著論文/症例報告)．末梢神経，28巻(1)，95-100，2017．
19. 滋賀健介. 神経疾患 126～128. 総合内科医の必修臨床問題182問. Medicina, 54巻(4)増刊号, 2017.
20. 中瀬泰然,師井淳太,石川達哉．心房細動の有無からみた抗凝固薬による脳梗塞二次予防の予後．脳卒中．39：480-484, 2017.
21. 中島 正之，初田 直樹，松尾 宏俊，丁 剛，谷本 匡浩，立川 弘孝. 初診時に末梢性めまいと診断された小脳梗塞に関する検討. 脳卒中 39 : 254-260, 2017
22. 石井亮太郎．片頭痛の軽減は脳梗塞のリスクを減少させるか．日本頭痛学会誌，44：25-29，2017．
23. 横関恵美, 巨島文子, 辻有希子, 濱中正嗣, 今井啓輔, 今田智美, 倉智雅子. 急性期脳梗塞による嚥下障害における改訂水飲みテストと1％とろみつき水飲みテストの併用法の有用性について. 脳卒中, 39: 12-18, 2016.
24. 芦田真士, 永金義成, 牧野雅弘, 友永慶, 蒔田直輝, 山本康正. 椎骨動脈から後大脳動脈におよぶ動脈解離をきたした脳梗塞の1例. 臨床神経学 57: 446-450, 2017.
25. 江畑琢矢，植村順一，山﨑英一，今井啓輔，八木田佳樹．両側内頚動脈閉塞を発症した高安動脈炎の１例．BRAIN and NERVE，69巻(6)665-669，2017．
26. 赤荻照章, 小林裕, 魚嶋伸彦, 前園恵子, 芦田真士, 池田佳弘. 発作性夜間ヘモグロビン尿症（PNH）と血栓症 －自施設での経験と考察－. 血液フロンティア, 9月号:80-86, 2017.
27. 松浦 啓, 蒔田 直輝, 石井 亮太郎, 藤田 泰子, 古野 優一, 水野 敏樹. 側頭葉に最大病変を認めたchronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids（CLIPPERS）の1例. 臨床神経, 57巻(7) 378-382, 2017.
2024年3月19日
2023年10月24日
2023年6月7日
2023年5月10日
2023年4月13日
